LINK: https://bswhealth.webex.com/bswhealth/j.php?MTID=m831b99e891e5c52e631d85f1e109fa7e
OBJECTIVES: Upon completion of this activity, the participant should be able to: (1) identify the history and mechanism of action for gabapentinoids, (2) describe spasticity, and (3) list research on gabapentinoids and spasticity.
FACULTY DISCLOSURE: Matthew Shonnard, MD, MPH has no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
PLANNER DISCLOSURE: The planners have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information, please contact Taylor Anne Shafer at Taylor.Shafer@BSWHealth.org
- 1.00 AMA PRA Category 1 Credit™The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 1.00 Attendance